Skip to content
MamaGLP — home
Menu

Evidence review

Zepbound vs Wegovy: Which One Is Right for You?

A calm comparison of Zepbound (tirzepatide) and Wegovy (semaglutide) — results, side effects, cost, and the details that matter most to a mom.

Written by Camila Rael, editoraa mom, not a clinician treating you

Every medical claim is cited to its primary source — the clinical trial or the FDA label — so you can open it and check it yourself. No one on this team is your healthcare professional. What follows is friendly information, never medical advice.

On this page

Two names you hear everywhere

If you are looking into GLP-1 medicines, two brand names have probably come up again and again: Wegovy and Zepbound. They sound alike, they are both once-weekly shots, they both help with weight loss… and they still are not the same. Let's go through them calmly, the way I would explain it to a friend who is trying to decide. There is no single "right" answer for everyone — there is one that fits you better.

The basics: what's inside each one?

  • Wegovy is semaglutide. It acts on one hormone pathway, the GLP-1 receptor — the signal your body uses after a meal to tell you you've had enough.
  • Zepbound is tirzepatide. It acts on two pathways at once, GLP-1 and GIP (which is why it's called a "dual agonist"). That second lever is why, on average, it tends to do a little more on the scale.

Both are serious medicines, approved for weight management, and both require a prescription and follow-up from a licensed clinician. Neither one is a shortcut or a "light" version of the other.

Results: which one takes off more weight?

Here we have something rare and genuinely valuable: a study that put them head to head. In the SURMOUNT-5 trial, adults with obesity (without diabetes) took one or the other for 72 weeks. Average weight loss was 20.2% with tirzepatide (Zepbound) versus 13.7% with semaglutide (Wegovy)1. People on tirzepatide were also more likely to reach reductions of 15%, 20%, and even 25%.

That lines up with what their individual studies already showed: semaglutide averaged around 15% in its large trial2, and tirzepatide came in around 20% or more at the higher doses3.

Now, an honest mom reminder: those are research averages, not promises. Your body, your history, and your daily life matter as much as the molecule does. A percentage that's "higher on paper" isn't always the better choice for the person who has to live it.

Side effects: more alike than you'd think

For both, the most common effects are digestive: some nausea, fullness, sometimes constipation or diarrhea. In the head-to-head comparison, gastrointestinal effects were the most frequent in both groups and were mostly mild to moderate and concentrated during dose escalation1. The reason is the same for both: your stomach empties a little more slowly, so you feel full sooner and for longer4.

The strategy that helps is the same too: start low, go up slowly, eat smaller portions, chew calmly, and drink water. If you want the practical detail, I go through it in GLP-1 side effects and how to manage them.

The mom angle: pregnancy, breastfeeding, and birth control

This almost never shows up in the ads, and for us it's one of the most important parts.

  • Pregnancy and breastfeeding: neither one is used during pregnancy or while trying to conceive, and neither is recommended while breastfeeding. That applies equally to Zepbound and Wegovy. If you're in your childbearing years, timing is a central part of the conversation; I get into it in GLP-1 and breastfeeding.
  • Birth control — here there is a real difference: with semaglutide (Wegovy), a dedicated study found it did not significantly reduce the absorption of a combined oral contraceptive pill5. With tirzepatide (Zepbound), by contrast, the FDA-approved labeling does warn that oral contraceptives may become less effective when you start the medication and at each dose increase, and it advises using a backup method (or switching to a non-oral one) during those weeks6.

If the pill is your birth-control plan, that difference can genuinely weigh on your decision. It's a concrete question to bring to your doctor.

Cost: both are expensive without insurance

Without coverage, both brands run over a thousand dollars a month at list price. There are manufacturer self-pay programs and other routes that bring the number down, and sometimes one is covered by your insurance and the other isn't — which in practice decides for you. I broke all of this down, including how to use an HSA or FSA, in GLP-1 without insurance: what it really costs. If price is your priority, also check our pick of more affordable options.

So, which one is right for you?

A simple way to think about it:

  1. If you're after the biggest average effect on the scale and you tolerate dose escalation well, tirzepatide (Zepbound) had the edge in the head-to-head comparison1.
  2. If the pill is your birth control and you'd rather have a lower chance of interaction, semaglutide (Wegovy) has that point in its favor5.
  3. If cost or coverage rules, the real answer is often "whichever one your insurance covers" or "whichever one your budget can carry month after month."

No website can decide this for you, and be wary of one that tries: this choice depends on your medical history, your goals, and your life. Our job is to leave you informed enough to have a good conversation. Here's how we score providers in our Mama-Match Score methodology, and our top pick, CoreAge Rx, is a calm, transparent front door for reviewing your full case with a licensed clinician. If you like comparing side by side, take a look at CoreAge Rx against other options too.

Take it at your own pace. The best decision is the informed one, not the rushed one. — Camila

This guide is educational only and is not medical advice. Some links may earn us a referral commission, at no cost to you and without changing our opinion. Decide together with a licensed healthcare professional.

Frequently asked questions

Does Zepbound take off more weight than Wegovy?

In a head-to-head comparison over 72 weeks (SURMOUNT-5), tirzepatide (Zepbound) averaged 20.2% weight loss versus 13.7% with semaglutide (Wegovy). Those are research averages, not promises: your result also depends on your body and your daily life.

Which one affects my birth control less?

Semaglutide (Wegovy) did not significantly reduce absorption of the combined pill in a dedicated study. Tirzepatide (Zepbound) does warn on its label that oral contraceptives may be less effective when starting and at each dose increase, and advises a backup method. Talk it through with your doctor.

Can I use either one while breastfeeding or trying to conceive?

No. Neither Zepbound nor Wegovy is used during pregnancy or while trying to conceive, and neither is recommended while breastfeeding. If you're in your childbearing years, timing is a key part of the conversation with your doctor.

References

  1. Aronne LJ, Horn DB, le Roux CW, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/40353578/
  2. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/33567185/
  3. Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/35658024/
  4. Urva S, Coskun T, Loghin C, et al. (2020). The novel dual GIP and GLP-1 receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists. Diabetes, Obesity and Metabolism. https://pubmed.ncbi.nlm.nih.gov/32519795/
  5. Kapitza C, Nosek L, Jensen L, et al. (2015). Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel. Journal of Clinical Pharmacology. https://pubmed.ncbi.nlm.nih.gov/25475122/
  6. Eli Lilly and Company (2025). Zepbound (tirzepatide) injection — Prescribing Information (FDA label, Drug Interactions: oral contraceptives). DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b

Friendly information, not a prescription. Everything on MamaGLP is here to help you understand your options and ask better questions — it is not a diagnosis, not a treatment plan, and not a nudge to start or stop anything. Only a licensed healthcare professional who knows your history and your goals can tell you what is right for you, so please talk with one before acting on a single word of this.